You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GRCE Buy Disclosure
Opaleye Management Inc. · SEC Form 4 · Filed Sep 10, 2026
Buy
Calculated transaction value
$12.2K
Opaleye Management Inc. 10% owner
GRCE
Grace Therapeutics
GRCE
Transaction date
Sep 9, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed 1 day later
GRCE daily price context
Close on/before transaction
$2.14
Sep 9, 2026
First close after public filing
$2.22
Sep 11, 2026
30-day return after filing
-9.01%
Through Oct 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.0001 per share
- Quantity / price
- 5,836 shares @ $2.09
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-042152
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$31.9K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Grace Therapeutics, Inc. GRCE Current | Buy | Sep 9, 2026 | $12.2K |
| Grace Therapeutics, Inc. GRCE | Buy | Sep 8, 2026 | $19.7K |